48
Participants
Start Date
March 8, 2021
Primary Completion Date
August 26, 2024
Study Completion Date
December 31, 2025
Hyperinsulemic euglycemic clamp
Following a 12-hour overnight fast at the CRU (including abstinence from caffeine containing foods and beverages), insulin sensitivity will be measured using the criterion method of the euglycemic clamp. Participants will have not performed vigorous physical activity for at least the previous 24 h, and be free of acute illness for the prior 2 weeks. An intravenous catheter will be placed in an antecubital vein for subsequent insulin (40 mU/m2-min) and glucose infusions and for stable isotope (6, 6-2H2) infusions to measure insulin sensitivity.
Muscle Biopsy
One biopsy taken prior to clamp and a second biopsy taken 30-45 min after the start of the clamp. A biopsy of the Vastus Lateralis muscle will be performed on the leg/thigh using the Bergstrom technique.
Oral abscisic acid (ABA)
Those in this group will receive ABA (95 µg ABA and 300 mg of corn starch)
Placebo
Those in this group will receive placebo (300 mg cornstarch)
AdventHealth Translational Research Institute, Orlando
Collaborators (1)
BioTherapeutics Inc.
INDUSTRY
AdventHealth Translational Research Institute
OTHER